Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a “Very High-Risk” Group?
2016 ◽
Vol 96
(2)
◽
pp. E240-E241
S. Choi
◽
L.B. Levy
◽
K.K. Lee
◽
Q.N. Nguyen
◽
A.K. Lee
◽
...
Noriyoshi Miura
◽
Naoya Sugihara
◽
Keisuke Funaki
◽
Toshio Kakuda
◽
Kanae Koyama
◽
...
2015 ◽
Vol 14
(2)
◽
pp. e1013-e1013a
M. Bianchi
◽
R.J. Karnes
◽
S. Joniau
◽
G. Gandaglia
◽
M. Spahn
◽
...
2018 ◽
Vol 13
(6)
◽
pp. e0199365
◽
Jae Won Park
◽
Dong Hoon Koh
◽
Won Sik Jang
◽
Joo Yong Lee
◽
Kang Su Cho
◽
...
N. Miura
◽
T. Okaichi
◽
S. Okamoto
◽
S. Mouri
◽
H. Sogabe
◽
...
Chad A. Reichard
◽
Justin R. Gregg
◽
Tharakeswala Bathala
◽
Mary F. Achim
◽
Quynh-Nhu Nguyen
◽
...
2020 ◽
Vol 108
(3)
◽
pp. e917
A. Yorozu
◽
S. Sutani
◽
T. Soyano
◽
H. Matsumoto
◽
K. Toya
◽
...
John DeLancey
◽
Richard Matulewicz
◽
Oliver Ko
◽
Edward Schaeffer
2018 ◽
Vol 127
◽
pp. S857
N.G. Di Muzio
◽
C.L. Deantoni
◽
C. Brombin
◽
C. Cozzarini
◽
S. Broggi
◽
...
2015 ◽
Vol 93
(3)
◽
pp. E236
A. Saad
◽
J.D. Goldstein
◽
Y. Lawrence
◽
D. Urban
◽
B. Spieler
◽
...
Marco Bianchi
◽
R. Jeffrey Karnes
◽
Steven Joniau
◽
Giorgio Gandaglia
◽
Martin Spahn
◽
...